Biotransformation of 16α,17-epoxy-ent-kaurane-19-oic acid (1) by Beauveria sulfurescens ATCC 7159-F led to the production of a new ent-kaurane diterpenoid, 7β,17-dihydroxy-ent-kaur-15-en-19-oic acid (7), and four other ent-kauranes (8 -11), all of which were identified as their methyl esters. Compounds 9 and 10 were found to be new stereoisomers. Structures of these were established by the extensive usage of their spectroscopic characteristics.
Microorganisms are effective biocatalysts in introducing hydroxyl groups at selective positions, especially the inactivated sites such as hydrocarbon motifs of organic molecules [1, 2] . Biotransformations of ent-kauranes by various microorganisms have been reported for enhancing their biological activities, studying their microbial metabolism, and in biosynthetic studies [2] . It is known that epoxide hydrolases of microorganisms are capable of stereoselective opening of epoxides yielding stereochemically pure diols [3] . Prompted by these reports, and as a part of our continuing studies on biotransformation of natural products and their analogues [4] , we have investigated biotransformation of 16α,17-epoxy-ent-kauran-19-oic acid (1) under a variety of conditions. Of the four fungal strains, Beauveria bassiana ATCC 7159, B. sulfurescens ATCC 7159-F, Cunninghamella echinulata var. elegans ATCC 10028 B, and Rhizopus stolonifer ATCC 6227 B, screened in potato dextrose broth (PDB) and a synthetic medium, only B. sulfurescens in the synthetic medium used caused complete biotransformation of 1. Biotransformation of 1 by Gibberella fujikuroi has previously resulted in the formation of 16α,17-dihydroxy-ent-kauran-19-oic acid and 16α,17-dihydroxygibberellin A 12 -7-aldehyde [5] .
A mixture containing 16α,17-epoxy-ent-kauran-19-oic acid (1) , and its 16β-epimer in the ratio of 9:1, obtained by the epoxidation (m-CPBA/CH 2 Cl 2 ) of ent-kaur-16-en-19-oic acid [5] , was incubated in the presence of B. sulfurescens for five days, and the culture broth was filtered and extracted with EtOAc. The EtOAc extract was found to be devoid of 1, but contained a complex and inseparable mixture of compounds. Methylation (MeI/K 2 CO 3 / acetone) of this afforded a mixture of methyl esters which on chromatographic separation resulted in isolation of 2-6 suggesting that ent-kauran-19-oic acids 7-11 were formed as biotransformation products of 1. (Figure 1) . Thus, the structure of 2 was elucidated as methyl 7β,17-dihydroxy-ent-kaur-15-en-19-oate (7) revealing the formation of the hitherto unknown ent-kaurane, 7β,17-dihydroxy-ent-kaur-15-en-19-oic acid (7), as a biotransformation product of 1.
Compound 3 was identified as methyl 16α,17-dihydroxy-entkauran-19-oate by extensive analysis of its NMR spectroscopic data. The unambiguous assignment of the stereochemistry at C-16 was made possible by the observed enhancement of the peak at δ 13 C NMR assignments of 3 have been made previously [8] and our data agreed well with those reported. However, the absence of 1 H NMR assignments of 3 made us to undertake complete interpretation of its 1 H NMR data (Table  2 ). This established the formation of 16α,17-dihydroxy-ent-kauran-19-oic acid (8) as a biotransformation product of 1. The major constituent of the EtOAc extract of the mycelium was identified as 8 by its spectroscopic data [8, 9] and confirmed by comparison of 1 H and 13 C NMR data of the methyl ester with those of 3.
Comparison of 1 H and 13 C NMR data of compound 4 with those of 2 ( Table 1 ) and 3 (Table 2) revealed that it is an ent-kaurane containing a 17-CH 2 OH [δ H 3.70 (d, J = 6.8 Hz); δ C 64.4)] and a CHOH [δ H 3.36 (dd, J = 11.6 and 3.6 Hz); δ C 75.9], but lacking the Δ 15 double bond. The COSY correlations exhibited by the signal at δ H 3.36 (dd) with those at δ 1.76 (m) and 2.07 (m) (6-H 2 ), together with the HMBC correlations of the protons at δ 1.11 (m) (5-H) and 1.76 (m)/2.07 (m) (6-H 2 ) to the hydroxymethylene carbon at δ 75.9 and the signal at δ H 3.36 (dd) (7-H) to δ C 31.8 (14-C) suggested the presence of an OH at C-7. From its 1 H-1 H coupling constants, 7-H was found to be of axial orientation indicating that the 7-OH group was α-oriented. Assignment of the stereochemistry at C-16 was made by NOEDIFF experiment in d 5 -pyridine in which the protons at C-11, C-12 and C-14 were well resolved in the 1 H NMR spectrum. In d 5 -pyridine, proton signals due to 17-CH 2 and 7-CH were shifted to down-field (δ 4.08 and 3.66, respectively). Upon irradiation of the signal at δ 4.08 in the NOEDIFF experiment, those at δ H 2.65 (m) (16-H), 1.92 (m) (12-H 2 ), and 1.73 (m) (11-H 2 ) were enhanced suggesting that the CH 2 OH at C-16 was β-oriented. Thus, the structure of 4 was elucidated as methyl 7α,17-dihydroxy-16α-ent-kauran-19-oate. Comparison of NMR data (CDCl 3 ) of 5 with those of 2, 3, and 4 (Tables 1 and 2) indicated that it also contained two OH groups. The COSY correlations between the signals at δ H 1.71 (m) (5-H) and 1.97 (m) (6-H 2 ), and the latter with the signal at δ H 3.60 (m) (7-H) suggested that 5 is the C-7 epimer of 4 and was confirmed by comparison of 1 H and 13 C NMR data with those reported [10] . This revealed the formation of 7α,17-dihydroxy-16α-ent-kauran-19-oic acid (9) and 7β,17-dihydroxy-16α-ent-kauran-19-oic acid (10) as biotransformation products of 1. C-16 epimers of both 9 and 10 have been reported as microbial biotransformation products of 17-hydroxy-16β-ent-kauran-19-oic acid by Calonectria decora [11] . 1 H and 13 C NMR data (CDCl 3 ) of compound 6 showed a very close resemblance to those of 3 ( Table 2 ) and revealed that it contained 17-CH 2 OH [δ H 3.62 and 3.71 (each d, J = 10.8 Hz); δ C 66.3)], 16α-OH, (δ C 82.1, 16-C), and an OH on a quaternary carbon (δ C 77.6). The assignment of stereochemistry at C-16 was further supported by comparison of its data with those reported for the related compounds, 16α,17-and 16β,17-dihydroxy-ent-kauran-19-al [9] . The HMBC correlation shown by the proton signal at δ 0.92 (20-H 3 ) to the carbon at δ 77.6 suggested the additional OH to be at C-9. These data led to the identification of 6 as methyl 9β,16α,17-trihydroxy-ent-kauran-19-oate, revealing 9β,16α,17-trihydroxy-entkauran-19-oic acid (11) as a biotransformation product of 1. Compound 11 has previously been reported as its glucopyranosyl ester, cofaryloside, from green coffee beans [12] , but this constitutes the first report of it as a microbial biotransformation product and complete assignment of its 1 H and 13 C NMR data.
It is well known that B. sulfurescens is capable of catalyzing a variety of biotransformation reactions including oxidation, epoxide Biotransformation of 16α,17-epoxy-ent-kaurane-19-oic acid Natural Product Communications Vol. 8 (8) 2013 1043 hydrolysis, and reduction of the double bond of α,β-unsaturated aldehydes and allylic alcohols [13] . In general, the acid catalyzed ring opening of epoxides occurs predominantly with inversion of configuration at the more substituted carbon. The presence of 8 and 11 as biotransformation products, in which configuration at C-16 was retained, suggests that the epoxide ring opening was catalyzed by an enzyme. Further, the presence of 8 as the major constituent in the mycelial extract led to the conclusion that the epoxide ring opening catalyzed by a microbial enzyme has taken place predominantly within the mycelium. It may be possible that compounds 7, 9, and 10 have originated from a common precursor containing Δ 15 double bond. Reduction of the double bond and hydroxylation at C-7 of such a precursor could lead to biotransformation products 9 and 10.
Experimental
General: 1D and 2D NMR spectra were recorded in CDCl 3 and/or d 5 -pyridine with a Bruker Avance III 400 spectrometer at 400 MHz for 1 H NMR and 100 MHz for 13 C NMR using residual solvent resonances as internal reference. LR-and HR-MS were recorded on Shimadzu LCMS-QP8000α and JEOL HX110A spectrometers respectively. Analytical and preparative thin layer chromatography (TLC) were performed on pre-coated 0.25 mm thick plates of silica gel 60 F 254 ; spraying with a anisaldehyde reagent followed by heating was used to visualize the spots on analytical TLC. Preparative HPLC was performed on a Waters Delta Prep 400 system equipped with a Waters 996 photodiode array detector and a Waters prep LC controller utilizing Empower Pro software and using a RP column (Phenomenex Luna 5 µm, C 18 , 100 Å, 250 x 10 nm) with a flow rate of 3.0 mL/min; chromatograms were acquired at 210 and 240 nm. 
Epoxidation of ent-kaur-16-en-19-oic acid: Ent-kaur-16-en-19-oic
acid (300 mg) was dissolved in CH 2 Cl 2 (8 mL) added m-CPBA (300 mg) and stirred at room temp for 2 h. The reaction mixture was diluted with CH 2 Cl 2 , washed with 10% Na 2 HCO 3 , dried over anh. Na 2 SO 4 and CH 2 Cl 2 was removed.
1 H NMR of the product showed the presence of a mixture containing 16β,17-and 16α,17-epoxy-entkaurane-19-oic acids, in 1:9 ratio, that was used for biotransformation without further purification. Erlenmeyer flasks, each holding 50 mL of the culture medium in a rotary shaker operating at 220 rpm at 28 °C for 24 h. Each flask was added 1% of a spore solution with absorbance of 0.8 at 600 nm. The substrate, 1 (2.0 mg in 50 μL of EtOH) was added to 48 h old culture and incubation continued. Fermentation broth of B. sulfurescens containing 50 μL EtOH without the substrate and the culture medium containing the substrate without the fungus served as the two controls. Both controls were incubated under the same conditions. Samples were taken from all three flasks at various time intervals, neutralized with NaOH, and extracted with EtOAc and the extracts were examined for the disappearance of 1 by TLC. Largescale biotransformation was performed under the same conditions but in 6 x 2 L flasks holding 1 L of the medium in each flask. A total of 240 mg of 1 dissolved in 6 mL of EtOH was distributed evenly among the six flasks, and incubated for 5 days.
Extraction and isolation:
The mycelia were removed by filtration, washed with H 2 O. The washings were combined with the filtrate, and neutralized with NaOH and extracted with EtOAc. The solvent was evaporated under reduced pressure to give the EtOAc extract (104.9 mg) as a yellow powder. The combined mycelia were lyophilized and extracted with EtOAc. The solvent was evaporated under reduced pressure to give the EtOAc extract (6.3 g) as yellow syrup.
The EtOAc extract (50 mg) of the culture broth was treated with MeI/K 2 CO 3 at 25 o C to give methyl esters of the biotransformation products. This mixture was chromatographed over an RP-C 18 column (1.5 g) made up in 10% CH 3 CN in H 2 O and eluted with increasing amounts of CH 3 CN in H 2 O in a stepwise gradient to yield 12 fractions. TLC purification of fraction 5 (eluent: 2% MeOH in EtOAc x 2) yielded compound 6 (1.60 mg, 3.2%, R f 0.54). Fraction 8 was subjected to HPLC purification on RP-C 18 column (eluent: 30 -90% CH 3 CN in H 2 O in 50 min) to afford compounds 2 (1.30 mg, 2.6%, t R 9.0 min), 5 (1.50 mg 3.0%, t R 23.0 min), and 4 (1.10 mg, 2.2%, t R 31.5 min). Purification of fraction 10 by prep TLC (eluent: 3% MeOH in CH 2 Cl 2 x 3) afforded compound 3 (4.00 mg, 8.0%, R f 0.35).
The EtOAc extract (6 g) of the mycelium was partitioned with hexanes and 80% aq. MeOH and the solvents were removed under reduced pressure to obtain hexanes (5.75 g) and aq. MeOH (246 mg) fractions. The aq. MeOH fraction (241 mg) was dissolved in EtOAc (200 mL) and treated with 0.5 M NaOH (200 mL). The EtOAc layer was washed with water, dried (Na 2 SO 4 ) and evaporated to give the neutral fraction (186.4 mg). The aqueous layer was acidified with 0.5 M HCl (pH = 2), extracted with EtOAc (3 x 300 mL) and the EtOAc layer was dried (Na 2 SO 4 ) and the solvent was removed to yield the acidic fraction (54 mg) which on recrystallization with hexanes gave compound 8 (27.0 mg; 0.45%). Supplementary data: 1D and 2D NMR spectra of 2 and 1D NMR spectra of 3-6 are available.
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